Literature DB >> 366453

Hereditary paroxysmal ataxia: response to acetazolamide.

R C Griggs, R T Moxley, R A Lafrance, J McQuillen.   

Abstract

From early childhood, eight patients in a kindred had paroxysmal bouts of ataxia, dysarthria, and nystagmus. The disorder was inherited as an autosomal dominant. Attacks occurred weekly and lasted 1 to 6 hours; there were slight cerebellar signs between attacks. Although the etiology was not determined, a serendipitous trial of acetazolamide completely abolished attacks, and all patients have remained free of attacks for as long as 5 years.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 366453     DOI: 10.1212/wnl.28.12.1259

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  39 in total

1.  Treatment of nystagmus.

Authors:  Matthew J Thurtell; R John Leigh
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

2.  Familial Episodic Ataxias and Related Ion Channel Disorders.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-09       Impact factor: 3.598

Review 3.  Pharmacological treatments of cerebellar ataxia.

Authors:  Masafumi Ogawa
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

4.  Unusual blink reflex with four components in a patient with periodic ataxia.

Authors:  T Yokota; H Hayashi; K Hirose; H Tanabe
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

5.  Current treatment of vestibular, ocular motor disorders and nystagmus.

Authors:  Michael Strupp; Thomas Brandt
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

6.  Familial dystonic choreoathetosis with myokymia; a sleep responsive disorder.

Authors:  E Byrne; O White; M Cook
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-12       Impact factor: 10.154

7.  Persistent superior oblique paresis as a manifestation of familial periodic cerebellar ataxia.

Authors:  P G Bain; G B Larkin; D M Calver; M D O'Brien
Journal:  Br J Ophthalmol       Date:  1991-10       Impact factor: 4.638

8.  A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias.

Authors:  M Strupp; R Kalla; J Claassen; C Adrion; U Mansmann; T Klopstock; T Freilinger; H Neugebauer; R Spiegel; M Dichgans; F Lehmann-Horn; K Jurkat-Rott; T Brandt; J C Jen; K Jahn
Journal:  Neurology       Date:  2011-07-06       Impact factor: 9.910

Review 9.  The cerebellum and migraine.

Authors:  Maurice Vincent; Nouchine Hadjikhani
Journal:  Headache       Date:  2007-06       Impact factor: 5.887

Review 10.  A pathogenetic classification of hereditary ataxias: is the time ripe?

Authors:  Giuseppe De Michele; Giovanni Coppola; Sergio Cocozza; Alessandro Filla
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.